About This Interstitial Cystitis Bladder Pain Syndrome Study
This study is evaluating an investigational drug (a drug not approved for clinical use) for the potential treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) in women. The investigational drug will be compared with a placebo (a substance that looks exactly like the investigational drug used in a study, except it does not contain any active ingredients).
IC/BPS is painful and may get in the way of social activities, exercise, intimacy, and sleep.
We need clinical research to evaluate the safety and effectiveness of IC/BPS treatments for women.
If you qualify, you will receive 1 treatment of either the investigational drug or placebo.
This portion of the study will last up to 28 weeks and will consist of up to 9 visits to the study center, including 2 phone visits.
After at least 12 weeks following the first treatment, you may choose to receive a second treatment. This second treatment will be the investigational drug. Depending on if and when you request a second treatment, your total participation in the study will last between approximately 26 to 46 weeks with a total of up to 13 visits.
Participants will also be asked to complete an electronic study diary to keep track of urination and bladder pain.